Agenus Begins Trading on Nasdaq After Reporting Quarterly Earnings
1 report, 1 independent
Updated Thu 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Agenus began trading on the Nasdaq stock exchange on November 5, 2026. The biotechnology company reported quarterly revenue of $31.49 million, surpassing the analyst estimate of $28.20 million. The firm also reported $0.02 earnings per share, which beat the consensus estimate of ($0.28) by $0.30.
From dailypolitical.com
Why it matters
The company's stock traded down $0.54 during midday trading following the earnings release. Analysts have recently issued varied ratings on the stock, including B. Riley Financial restating a "buy" rating and Rodman & Renshaw setting a "buy" rating with a $19.00 target price.
From dailypolitical.com
Who's involved
- NasdaqStock exchange where Agenus began trading
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Materialise listed its shares on the Nasdaq stock exchange on August 27, 2026.
- Harte Hanks was listed on the Nasdaq stock exchange on August 14, 2026.
- Aaron was listed on the Nasdaq stock exchange today.
- Company Q783794 was listed on the Nasdaq stock exchange.
- Koss Corporation was listed on the stock exchange on August 1, 2026.